These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38462520)

  • 21. Peripheral COMT inhibition prevents levodopa associated homocysteine increase.
    Müller T; Muhlack S
    J Neural Transm (Vienna); 2009 Oct; 116(10):1253-6. PubMed ID: 19657587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
    Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill
    LeWitt PA; Giladi N; Navon N
    Parkinsonism Relat Disord; 2019 Aug; 65():131-138. PubMed ID: 31176632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Physicochemical Stability of the L-DOPA Extract of
    Vilairat C; Kobtrakul K; Vimolmangkang S
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference.
    Müller T
    Patient Prefer Adherence; 2009 Nov; 3():51-9. PubMed ID: 19936145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report.
    Radder DLM; Tiel Groenestege AT; Boers I; Muilwijk EW; Bloem BR
    J Parkinsons Dis; 2019; 9(2):437-439. PubMed ID: 30856121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levodopa-Reduced
    Johnson SL; Park HY; DaSilva NA; Vattem DA; Ma H; Seeram NP
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30131460
    [No Abstract]   [Full Text] [Related]  

  • 28. Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia.
    Hauser RA; Zeitlin L; Fisher S; D'Souza R
    J Parkinsons Dis; 2020; 10(3):915-925. PubMed ID: 32568108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models.
    Rijntjes M
    Parkinsons Dis; 2019; 2019():1349509. PubMed ID: 31781363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seed extract of Thai Mucuna pruriens (L.) DC. var. pruriens enhances sexual performance and improves male reproductive damages in ethanol-induced rats.
    Tangsrisakda N; Kamollerd T; Taoto C; Bunsueb S; Chaimontri C; Choowong-In P; Lapyuneyong N; Wu AT; Thukhammee W; Wattanathorn J; Arun S; Sawatpanich T; Iamsaard S
    J Ethnopharmacol; 2022 Jun; 292():115219. PubMed ID: 35339625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease.
    Kestenbaum M; Fahn S
    Expert Opin Drug Saf; 2015 May; 14(5):761-7. PubMed ID: 25697185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson disease.
    Müller T; Kolf K; Ander L; Woitalla D; Muhlack S
    Clin Neuropharmacol; 2008; 31(3):134-40. PubMed ID: 18520980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa.
    LeWitt P; Liang GS; Olanow CW; Kieburtz KD; Jimenez R; Olson K; Klepitskaya O; Loewen G
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):43-50. PubMed ID: 36688497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucuna pruriens and its major constituent L-DOPA recover spermatogenic loss by combating ROS, loss of mitochondrial membrane potential and apoptosis.
    Singh AP; Sarkar S; Tripathi M; Rajender S
    PLoS One; 2013; 8(1):e54655. PubMed ID: 23349947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures.
    Pathak-Gandhi N; Vaidya AD
    J Ethnopharmacol; 2017 Feb; 197():46-51. PubMed ID: 27544001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease.
    Modak A; Durso R; Josephs E; Rosen D
    J Parkinsons Dis; 2012; 2(4):349-56. PubMed ID: 23646099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson's disease: is it an improvement on other delivery?
    Doggrell SA
    Expert Opin Drug Deliv; 2023; 20(9):1189-1199. PubMed ID: 37634938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients.
    Stocchi F; Hsu A; Khanna S; Ellenbogen A; Mahler A; Liang G; Dillmann U; Rubens R; Kell S; Gupta S
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1335-40. PubMed ID: 25306200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease.
    Müller T; Erdmann C; Muhlack S; Bremen D; Przuntek H; Goetze O; Woitalla D
    J Neural Transm (Vienna); 2006 Oct; 113(10):1441-8. PubMed ID: 16604302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease.
    Nomoto M; Nagai M; Nishikawa N; Ando R; Kagamiishi Y; Yano K; Saito S; Takeda A
    eNeurologicalSci; 2018 Dec; 13():8-13. PubMed ID: 30294682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.